← Back
$KYTX All transactions

Kyverna Therapeutics, Inc.

A

$ Value

$0

Shares

350,000

Price

$0

Filed

Mar 17

Insider

Name

Biddle Warner Weston

Title

Chief Executive Officer

CIK

0002034523

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-13

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

350,000

Footnotes

Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. | 1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Filing Info

Accession No.

0001193125-26-110920

Form Type

4

Issuer CIK

0001994702

Biddle Warner Weston's History

Date Ticker Type Value
2026-03-13 KYTX A $0
2026-03-13 KYTX A $0

Other Insiders at KYTX (90d)

Insider Bought Sold Last
GRASSO MARC
Chief Financial Officer
2026-03-13
Miller Andrew Craig 2026-02-24
Emany Sravan Kumar 2026-02-24
Biddle Warner Weston
Chief Executive Officer
2026-03-13
GEHCHAN NAJI
See Remarks
2026-03-13
Pujols Mayobanex
Chief Technology Officer
2026-02-09